Haywire T cells attack protein in "bad" cholesterol
Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries.
2 hours ago
0
33
Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries.
2 hours ago
0
33
FRIDAY, May 20, 2022 (American Heart Association News)—Just a few days after Dottie Lewis and her husband, Wayne, returned from vacation to their home in Plymouth, Massachusetts, she started feeling poorly.
5 hours ago
0
6
The Society for Cardiovascular Angiography & Interventions (SCAI) today released official guidelines for the management of patent foramen ovale (PFO). A multidisciplinary guideline panel formulated 13 recommendations to address ...
May 19, 2022
0
0
New data from a study of more than 100 million hospitalizations using machine learning augmentation is being presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The findings ...
May 19, 2022
0
3
Insights from a National Inpatient Sample Database examining race and the rates of cardiac catheterization or revascularization for acute coronary syndrome (ACS) patients with a history of cocaine use is being presented today ...
May 19, 2022
0
0
Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention (DIPRA) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography ...
May 19, 2022
0
1
Results from a retrospective analysis reveal significantly higher mortality rates for low-income residents hospitalized with ST-elevation myocardial infarction (STEMI) when compared to higher-income residents. The findings ...
May 19, 2022
0
1
New findings from the Ascension Health System's internal National Cardiovascular Data Registry (NCDR) analyzing rates of percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in parallel ...
May 19, 2022
0
0
One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous transluminal angioplasty (PTA) with a DCB was presented today as late-breaking clinical ...
May 19, 2022
0
1
The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The ...
May 19, 2022
0
1